Bailard, Inc. Dynavax Technologies Corp Transaction History

Bailard, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$7.25 - $10.99 $145,000 - $219,800	-20,000 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$4.57 - $11.18 $91,400 - $223,600	20,000 New	20,000 $197,000
Q4 2020 Feb 03, 2021	SELL	$3.73 - $5.6 $999,640 - $1.5 Million	-268,000 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$4.32 - $11.7 $207,360 - $561,600	48,000 Added 21.82%	268,000 $1.16 Million
Q2 2020 Aug 12, 2020	BUY	$2.94 - $9.1 $646,800 - $2 Million	220,000 New	220,000 $1.95 Million
Q2 2019 Jul 26, 2019	SELL	$3.65 - $7.89 $543,850 - $1.18 Million	-149,000 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$7.08 - $12.09 $364,620 - $622,635	51,500 Added 52.82%	149,000 $1.09 Million
Q4 2018 Feb 05, 2019	SELL	$8.14 - $13.28 $793,650 - $1.29 Million	-97,500 Reduced 50.0%	97,500 $892,000
Q3 2018 Nov 13, 2018	BUY	$11.85 - $16.0 $1.78 Million - $2.4 Million	150,000 Added 333.33%	195,000 $2.42 Million
Q2 2018 Aug 08, 2018	BUY	$15.15 - $20.75 $681,750 - $933,750	45,000 New	45,000 $686,000

288

131M

507K

374K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.74B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.